| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://zenotechlab.com | |
| Market Cap | 360.08 Cr. | |
| Enterprise Value(EV) | 363.64 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.68 | Trailing Twelve Months Ending 2022-06 |
| Price-Earning Ratio (PE) | 16.04 | Trailing Twelve Months Ending 2022-06 |
| Industry PE | 31.29 | Trailing Twelve Months Ending 2022-06 |
| Book Value / Share | 12.19 | Trailing Twelve Months Ending 2022-06 |
| Price to Book Value | 4.84 | Calculated using Price: 59.00 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 6.10 Cr. | 61,030,568 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world. | ||
| 1 Day |
|
-2.96% |
| 1 Week |
|
-2.13% |
| 1 Month |
|
-1.20% |
| 3 Month |
|
+1.95% |
| 6 Month |
|
+14.67% |
| 1 Year |
|
+21.85% |
| 2 Year |
|
+73.83% |
| 5 Year |
|
+32.68% |
| 10 Year |
|
+75.69% |
| 9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | -65.67 | -155.73 | -7.73 | 24.35 | -2.48 | |||||
| Return on Capital Employed (%) | -48.47 | -39.28 | -61.52 | -65.68 | -61.88 | -5.95 | 18.32 | 0.48 | ||
| Return on Assets (%) | -37.69 | -33.32 | -45.43 | -32.82 | -38.33 | -17.89 | -3.76 | 12.67 | -1.42 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
| Shh. Funds | 26 | 3 | -27 | -46 | -66 | 42 | 39 | 50 | 48 | 71 | |
| Non Curr. Liab. | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | -4 | |
| Curr. Liab. | 40 | 66 | 91 | 99 | 116 | 39 | 45 | 35 | 15 | 16 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 67 | 70 | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | |
| Non Curr. Assets | 62 | 59 | 55 | 50 | 49 | 50 | 65 | 80 | 79 | 74 | |
| Curr. Assets | 5 | 11 | 8 | 3 | 2 | 31 | 19 | 6 | 7 | 7 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 67 | 70 | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
| Net Sales | 3 | 3 | 4 | 2 | 2 | 11 | 13 | 26 | 22 | 39 | |
| Other Income | 0 | 3 | 0 | 0 | 0 | 2 | 5 | 1 | 0 | 1 | |
| Total Income | 3 | 5 | 4 | 2 | 2 | 14 | 18 | 27 | 23 | 40 | |
| Total Expenditure | -24 | -20 | -24 | -10 | -13 | -19 | -17 | -17 | -16 | -20 | |
| PBIDT | -21 | -15 | -20 | -8 | -10 | -6 | 1 | 10 | 7 | 20 | |
| Interest | -1 | -5 | -7 | -8 | -8 | -2 | 0 | -1 | -2 | -1 | |
| Depreciation | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -5 | -6 | -7 | |
| Taxation | 11 | ||||||||||
| Exceptional Items | 2 | 6 | |||||||||
| PAT | -26 | -23 | -30 | -19 | -20 | -12 | -3 | 11 | -1 | 22 | |
| Adjusted EPS | -7 | -6 | -8 | -5 | -5 | -2 | -1 | 2 | 0 | 4 |
| Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | -10 | -24 | -8 | -5 | 2 | -16 | -14 | 11 | 6 | |
| Cash Fr. Inv. | 0 | 0 | -1 | 0 | 6 | -1 | -3 | -16 | -21 | -5 | |
| Cash Fr. Finan. | 2 | 10 | 30 | 7 | -1 | -1 | 47 | 15 | -3 | 0 | |
| Net Change | 0 | 0 | 5 | -1 | 0 | 0 | 28 | -15 | -12 | 1 | |
| Cash & Cash Eqvt | 2 | 2 | 6 | 6 | 0 | 0 | 28 | 13 | 1 | 2 |
|
Mon, 26 Sep 2022
Closure of Trading Window This is to inform you that in compliance with the Companys Code of Conduct for Prevention of Insider Trading the window closure for trading by Designated Persons of the Company (along with his/her immediate relatives or any person with whom he/she shares a material financial relationship) shall be with effect from Saturday October 1 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022. The date of the Board Meeting of the Company for declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022 will be intimated in due course. |
|
Sat, 24 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of the 33rd Annual General Meeting of Zenotech Laboratories Limited held on September 24 2022 |
|
Sat, 24 Sep 2022
Chairperson Speech At The 33Rd Annual General Meeting We are pleased to enclose herewith Chairperson Speech at the 33rd Annual General Meeting held on September 24 2022. |
| Thu, 29 Sep 2022 |
High Delivery Percentage
|
Opening at High
|
High Increase 2 Years
|
| Wed, 28 Sep 2022 |
|
High Delivery Percentage
|
|
Opening at High
|
Equities
M.F.
Sectors